Shirisha or Vasaka: Which One for Allergies or Cough?

Shirisha and vasaka both belong to the respiratory sphere of the Ayurvedic pharmacopoeia, but their traditional uses don't really overlap: shirisha is positioned more on the allergic terrain, tulsi/">vasaka on productive cough and congested bronchi.

Two distinct respiratory terrains

Criterion	Shirisha	tulsi/">Vasaka
Botanical name	Albizia lebbeck	Adhatoda vasica
Target terrain	Allergies, skin and respiratory reactions	Productive cough, congested bronchi
Suggested mechanism	Action on histamine signaling	Bronchodilator and expectorant effect
Evidence level	Preclinical	Preclinical
Typical use	Ongoing cure during allergy season	Short, occasional cure for the episode

What the research shows on shirisha

Preclinical work on Albizia lebbeck has explored anti-allergic activity of the plant's standardized extract, with a catechin-based phytomarker identified as active (see the literature on Google Scholar). Other work has explored a more precise mechanism, an action of Albizia lebbeck on histamine signaling — the H1 histamine receptor and histidine decarboxylase, two central players in the allergic reaction (see the literature on Google Scholar). This data remains lab-based or animal-model work; no large controlled human trial is available to date to confirm comparable efficacy in human respiratory or skin allergy.

What the research shows on vasaka

A phytochemical and pharmacological review dedicated to Adhatoda vasica documents bronchodilator and expectorant properties traditionally attributed to the plant, with plausible pharmacological mechanisms identified in the lab (see the review on Google Scholar). That same review notes, however, that these findings remain largely preclinical: large-scale controlled human trials, meeting current standards, are still lacking to confirm comparable efficacy in human cough or asthma — a point already detailed in our comparison vasaka or tulsi. This is a case where pharmacological plausibility is stronger than for many Ayurvedic herbs, without that being enough to make it a validated treatment.

How to choose based on your need

• Known allergic terrain, recurring skin or respiratory reactions during risk periods: shirisha is traditionally positioned on this terrain, as an ongoing cure, without replacing a prescribed antihistamine treatment for confirmed allergy.
• Productive cough, feeling of congested bronchi, an occasional episode: vasaka is the most targeted traditional choice, as a short cure for the duration of the episode.
• Diagnosed asthma or cough persisting beyond a few days: neither herb replaces medical advice; a cough that lasts, worsens, or comes with fever or shortness of breath should be evaluated by a healthcare professional.
• Children: extra caution applies to both herbs, for lack of specific pediatric data; medical advice is recommended before any use.

Indicative dosage for each

As a general guide, to adapt with a professional:

• Shirisha: trunk bark powder (churna), 2 to 4 g per day in 1 to 2 doses, often with a little honey, or decoction (kwath), one cup a day — details in shirisha dosage.
• Vasaka: used as a short, occasional cure for the duration of a cough or congested-bronchi episode, rather than continuously — details in vasaka dosage.

Precautions

• Pregnancy and breastfeeding: cautious use is recommended for both herbs, for lack of sufficiently robust safety data in this context.
• Ongoing antihistamine or cough-suppressant treatment: mention taking these herbs to your doctor or pharmacist, particularly with a chronic treatment for an allergy or respiratory condition.
• Asthma, chronic bronchitis, persistent cough: these situations call for medical diagnosis and follow-up; herbs can only be considered alongside professional advice.
• No solid clinical data today guarantees efficacy comparable to a medical treatment for allergy or cough for either herb.

General safety guidance is detailed in our safety and precautions guide.